CPHI vs EXPE · rev $4.1M vs P/E 20, rev $13.69B
China Pharma Holdings Inc (CPHI) versus Expedia Group Inc. (EXPE) — a side-by-side from cached financials, not a winner call.
China Pharma Holdings Inc (CPHI) is a drug manufacturers - specialty & generic company listed on US.
Expedia Group Inc. (EXPE) is a travel services company listed on US.
Latest reported CPHI revenue for 2025-12-31 was $4.1M. Net income was -$3.2M. Revenue was down 8.5% from 2024-12-31 to 2025-12-31. CPHI currently screens at market cap $29.0M.
Latest reported EXPE revenue for 2024-12-31 was $13.69B. Net income was $1.22B. Revenue was up 6.6% from 2023-12-31 to 2024-12-31. EXPE currently screens at market cap $21.71B and trailing P/E 20.4.
CPHI currently screens at market cap $29.0M. EXPE currently screens at market cap $21.71B and trailing P/E 20.4.
Not investment advice. Open the CPHI and EXPE stock pages for the full models.
Not investment advice.